Citrini Bets on Life Sciences After Claude AI Drug Study

Bloomberg
Read the full article
Citrini Research highlights the potential benefits for life sciences companies from AI-driven drug discovery after evaluating Anthropic PBC's Claude Science model. The study underscores AI's growing role in advancing pharmaceutical research.

More in Healthcare

UnitedHealthcare Is Rolling Out Its AI Agent To 21 Million Members

Forbes
Healthcare1 min read

Remote embalming and shipment for brain or whole body preservation with Sparks

LessWrong
Healthcare6 min read

symplr Launches AI Time and Scheduling to Predict Healthcare Staffing Needs

Unite.AI